* * *
Speaker 1 (00:00):
Well, this is in fact today,
Speaker 2 (00:03):
Not about a future plan. This is the
platform which is you start with a digital front door. Lets say you have a chronic condition or multiple chronic conditions, which are the folks that cost the most money in our healthcare system. So if you have type two diabetes, 70% of the
people with type two diabetes also have hypertension, a high percentage of those people have a weight management issue. And if youre dealing with multiple chronic conditions, you may at times have a behavioral or mental health issue, which is
you might get tired of it. You might get depressed about it. So all of those fit together, very nicely, those same people, um, occasionally get a sinus infection or occasionally have other issues. And to have one platform, you know, they used to
call us in the middle of the night and theyd say, I have a sinus infection.
Speaker 2 (00:53):
Wed say, well, why are you calling us? And theyd say, well, number one, youre the only ones who will answer the phone. Number two are the
only ones who are responsive. And number three, youre the only ones we trust. So we started to say, well, this is a real need. How do we solve that need for our members? And we started to talk with all the different telehealth providers. And
ultimately as the pandemic came along, we got to see how they perform under pressure. We started to look at what would we do to satisfy the ultimate objective of Lavaca, which is empowering more people around the world with chronic conditions to
live better and healthier lives and tell it that kind of 70 million, theyre there. 70 million people around the world have access to Teladoc. So think about that. Probably half of those people have a chronic condition. They will now
have access to a.
Cautionary Note Regarding Forward-Looking Statements
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements regarding the potential transaction between Teladoc
Health, Inc. (Teladoc) and Livongo Health, Inc. (Livongo), including any statements regarding the expected timetable for completing the potential transaction, the ability to complete the potential transaction, the expected
benefits of the potential transaction (including anticipated synergies, projected financial information and future opportunities) and any other statements regarding Teladocs and Livongos future expectations, beliefs, plans, objectives,
results of operations, financial condition and cash flows, or future events or performance. These statements are often, but not always, made through the use of words or phrases such as anticipate, intend, plan,
believe, project, estimate, expect, may, should, will and similar expressions. All such forward-looking statements are based on current expectations of
Teladocs and Livongos management and therefore involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the results expressed in the
statements. Key factors that could cause actual results to differ materially from those projected in the forward-looking statements include the ability to obtain the requisite Teladoc and Livongo stockholder approvals; uncertainties as to the timing
to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that the anticipated U.S. federal income tax treatment of the transaction is not obtained; litigation relating to
the potential